Answers are grounded in this paper and cite their sources.
Substantial delays between the onset of pulmonary arterial hypertension (PAH) symptoms and diagnosis of the disease continue for the majority of PAH patients. The delays persist despite a growing number of effective treatments and the knowledge that early initiation of therapy is clinically beneficial. Patients need to be encouraged not to rationalize their symptoms when they do occur but to seek medical evaluation. Physicians should be alert to the common symptoms found at PAH presentation and recognize that patients may have comorbid conditions that mask the disease. The goal of identifying patients at the earliest stages of functional impairment will not be achieved unless PAH is considered as a possible diagnosis.
No takes yet. Share an insight, caveat, or question.
Brown et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: